Prime Medicine, Inc. Common Stock Earnings
The next earnings date for Prime Medicine, Inc. Common Stock is November 6, 2026.
They are scheduled to announce earnings before the market opens that day.
Analyst Estimates of Prime Medicine, Inc. Common Stock Earnings
| 11/06/2026 | $-0.23 |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Prime Medicine, Inc. Common Stock Earnings: Historical
| 08/06/2026 | Before Market | $-0.24 | 0.00% |
| 05/07/2026 | Before Market | $-0.28 | -12.00% |
| 03/03/2026 | --- | $-0.24 | 6.90% |
| 11/07/2025 | Before Market | $-0.32 | -28.00% |
| 08/07/2025 | Before Market | $-0.41 | -13.89% |
| 05/08/2025 | Before Market | $-0.40 | -29.03% |
| 02/28/2025 | --- | $-0.31 | 36.73% |
| 11/12/2024 | After Market | $-0.44 | -4.76% |
| 08/08/2024 | Before Market | $-0.46 | -17.95% |
| 05/10/2024 | Before Market | $-0.44 | 4.35% |
More About Prime Medicine, Inc. Common Stock
Prime Medicine, Inc., a biotechnology company, engages in delivering genetic medicines to address the spectrum of diseases by deploying gene editing technology in the United States. Its lead therapeutic product candidate is PM359 for Chronic Granulomatous Disease, which is in Phase 1/2 clinical trial; PM577 for Wilson Disease, that is in preclinical studies; and PM647 to treat genetic disorder caused by mutations in the SERPINA1 gene, resulting in production of misfolded Z-AAT protein that accumulates in the liver and leads to hepatocellular injury, cirrhosis, and increased risk of hepatocellular carcinoma. The company also provides vivo programs targeting diseases of the liver, and Cystic Fibrosis programs. In addition, it offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor. The company has a research collaboration and license agreement with BMS; Cystic Fibrosis Foundation; Broad Institute; and Beam. Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
“Prime Medicine, Inc. Common Stock Earnings” Can Refer to the Prime Medicine, Inc. Common Stock Earnings Date
Some people say “Prime Medicine, Inc. Common Stock earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Prime Medicine, Inc. Common Stock position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Prime Medicine, Inc. Common Stock Stock on the Earnings Date
If you own Prime Medicine, Inc. Common Stock stock (PRME) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Prime Medicine, Inc. Common Stock might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Prime Medicine, Inc. Common Stock shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Prime Medicine, Inc. Common Stock Earnings
You can contact us any time if you would like to ask questions about Prime Medicine, Inc. Common Stock earnings or anything else related to the stock market.